Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,897 | 1,093 | 99.8% |
| Education | $34.07 | 7 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,735 | 121 | $0 (2024) |
| Novo Nordisk Inc | $1,469 | 149 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,190 | 74 | $0 (2024) |
| Amgen Inc. | $1,072 | 60 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $844.23 | 69 | $0 (2020) |
| Merck Sharp & Dohme LLC | $821.12 | 68 | $0 (2024) |
| ABBVIE INC. | $725.29 | 48 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $721.64 | 53 | $0 (2022) |
| Allergan, Inc. | $596.87 | 51 | $0 (2020) |
| Lilly USA, LLC | $573.73 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,493 | 68 | AstraZeneca Pharmaceuticals LP ($326.98) |
| 2023 | $1,299 | 77 | AstraZeneca Pharmaceuticals LP ($238.99) |
| 2022 | $1,491 | 89 | Boehringer Ingelheim Pharmaceuticals, Inc. ($260.08) |
| 2021 | $2,184 | 141 | AbbVie Inc. ($383.10) |
| 2020 | $1,793 | 123 | AstraZeneca Pharmaceuticals LP ($343.04) |
| 2019 | $2,191 | 125 | AstraZeneca Pharmaceuticals LP ($639.24) |
| 2018 | $2,665 | 225 | AstraZeneca Pharmaceuticals LP ($440.10) |
| 2017 | $2,815 | 252 | Novo Nordisk Inc ($466.03) |
All Payment Transactions
1,100 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Biological | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: DIABETES | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: Biological | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: Inflammation | ||||||
| 10/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Inflammation | ||||||
| 10/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: GI | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: PAIN | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Biological | ||||||
| 10/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Biological | ||||||
| 09/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Diabetes | ||||||
| 09/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Biological | ||||||
| 08/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: DIABETES | ||||||
| 07/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,185 | 2,443 | $413,342 | $226,588 |
| 2022 | 13 | 1,319 | 2,778 | $450,760 | $248,812 |
| 2021 | 12 | 1,160 | 2,680 | $371,676 | $222,679 |
| 2020 | 14 | 1,237 | 2,712 | $390,762 | $203,008 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 388 | 1,197 | $189,126 | $109,746 | 58.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 233 | 233 | $46,600 | $31,385 | 67.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 145 | 272 | $59,840 | $26,146 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 351 | $37,908 | $23,713 | 62.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 118 | 261 | $52,200 | $17,919 | 34.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 26 | 33 | $9,570 | $7,623 | 79.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $10,038 | $4,331 | 43.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 18 | $3,960 | $3,071 | 77.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $3,220 | $2,401 | 74.6% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 18 | 22 | $880.00 | $253.27 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 373 | 1,063 | $167,954 | $93,144 | 55.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 240 | 623 | $67,284 | $40,468 | 60.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 185 | 185 | $37,000 | $25,263 | 68.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 139 | 313 | $62,600 | $23,306 | 37.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 105 | 151 | $33,220 | $15,289 | 46.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 51 | 179 | $26,850 | $14,917 | 55.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 67 | 67 | $15,410 | $11,758 | 76.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 26 | 32 | $9,280 | $7,420 | 80.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 37 | 40 | $11,720 | $6,398 | 54.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 23 | 23 | $5,060 | $3,958 | 78.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 30 | 38 | $5,890 | $3,286 | 55.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $6,692 | $3,268 | 48.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 36 | $1,800 | $339.22 | 18.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 402 | 998 | $157,684 | $90,827 | 57.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 299 | 1,010 | $109,080 | $69,068 | 63.3% |
About Dr. Asela Wickremasinghe, M.D
Dr. Asela Wickremasinghe, M.D is a Internal Medicine healthcare provider based in Hanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164476081.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Asela Wickremasinghe, M.D has received a total of $15,931 in payments from pharmaceutical and medical device companies, with $1,493 received in 2024. These payments were reported across 1,100 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($15,897).
As a Medicare-enrolled provider, Wickremasinghe has provided services to 4,901 Medicare beneficiaries, totaling 10,613 services with total Medicare billing of $901,086. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Hanford, CA
- Active Since 05/22/2006
- Last Updated 10/09/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1164476081
Products in Payments
- FARXIGA (Drug) $1,579
- JARDIANCE (Drug) $1,128
- Ozempic (Drug) $677.53
- XARELTO (Drug) $635.18
- JANUVIA (Drug) $585.25
- Victoza (Drug) $584.85
- Vascepa (Drug) $512.43
- LINZESS (Drug) $430.81
- EVENITY (Biological) $425.70
- BREZTRI (Drug) $406.95
- NURTEC ODT (Drug) $390.12
- ANORO (Drug) $363.43
- Linzess (Drug) $348.55
- UBRELVY (Drug) $324.35
- TOUJEO (Drug) $287.18
- Prolia (Biological) $264.77
- Yupelri (Drug) $259.54
- Otezla (Drug) $259.11
- EMGALITY (Drug) $255.03
- BYDUREON (Drug) $247.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hanford
Carlos Santivanez, M.d, M.D
Internal Medicine — Payments: $134,387
Dr. John Gavini, M.d, M.D
Internal Medicine — Payments: $14,039
Sudesh Nagavalli, Md, MD
Internal Medicine — Payments: $12,202
Dr. H Kiran Reddy, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $11,042
Susan Locke, M.d, M.D
Internal Medicine — Payments: $1,663
Dr. Robert Woods, M.d, M.D
Internal Medicine — Payments: $1,244